Chinese Clinical Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.7 | Q3 | 44.7% | 0.636 | Q2 | 69.6% |
| 2024 | 2.5 | Q3 | 42.6% | 0.632 | Q2 | 70.2% |
| 2023 | 2.1 | Q3 | 33.7% | 0.690 | Q2 | 75.2% |
| 2022 | 2.8 | 39.8% | 0.565 | Q2 | 70.1% | |
| 2021 | — | 25.2% | 0.642 | Q2 | 74.9% | |
| 2020 | — | — | 0.733 | Q2 | 77.4% | |
| 2019 | — | — | 0.763 | Q2 | 79.2% | |
| 2018 | — | — | 0.656 | Q2 | 73.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2304-3865
ISSN
2304-3873
country
HKcoverage
2012-2026